Article

Toll Like Receptor 4 and IFNγ Signalling axis as a therapeutic target in Triple negative Breast Cancer

2024-12-04

Abstract excerpt

<title>Abstract</title> <p>Triple Negative Breast Cancer (TNBC) is a hormone-receptor-negative (ER/PR/Her2)- subtype of breast cancer which has an immunogenic character and shows extensive molecular heterogeneity. TLRs (Toll like receptors) are a class of pattern recognition receptors regulating innate immune response. In the present study, we want to envisage the immunomodulatory role of TLR4 in TNBC. The TLR ex...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5c38f1f1-9de0-5234-a3fd-159412de8c0e
DOI: 10.21203/rs.3.rs-5395333/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Toll Like Receptor 4 and IFNγ Signalling axis as a therapeutic target in Triple negative Breast CancerDOI 10.21203/rs.3.rs-5395333/v1Read

High expression of TLR3 in triple-negative breast cancer predicts better prognosis —data from the Fudan University Shanghai Cancer Center cohort and tissue microarraysSemantic proximity Read

A Comprehensive Immunologic Portrait of Triple-Negative Breast CancerSemantic proximity Read

Classification of triple-negative breast cancer based on immune cell infiltrationSemantic proximity Read

CRTAM promotes antitumor immune response in triple negative breast cancer by enhancing CD8+ T cell infiltrationSemantic proximity Read

A comprehensive analysis of immune landscape of Indian triple negative breast cancerSemantic proximity Read

Impact of estrogen and progesterone hormone receptors on the progression of interferon-γ sensitized breast cancer cellsSemantic proximity Read

CD8-positive T cells are key immune cells for predicting the therapeutic effect of neoadjuvant chemotherapy in triple-negative breast cancerSemantic proximity Read

Clinical relevance of the immune contexture and AXL kinase in triple-negative breast cancerSemantic proximity Read

Interleukin-17-based cytokine signaling as a determinant for tumor immune microenvironment with prognostic value in triple-negative breast cancerSemantic proximity Read

Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor BehaviorSemantic proximity Read

Advances in immunotherapy for triple-negative breast cancerSemantic proximity Read

A CTL/M2 Macrophage-Related Four-Gene Signature Predicting Metastasis-Free Survival in Triple-Negative Breast Cancer Treated with Adjuvant RadiotherapySemantic proximity Read